walah yang ada di indo tuh banyakan pil, tapi hati hati sekarang banyak produsen yang memproduksi pil pochai ini. jadi beli pochai pill yang asli dari hongkong bukan dari produsen yang lain.
11 Po Chai pill samples found tainted
*
Department of Health
A total of 11 samples of Li Chung Shing Tong's Po Chai Pills were found to contain western drugs phenolphthalein and sibutramine, the Department of Health says.
The Government Laboratory today completed testing on all the 153 samples of Po Chai Pills in bottle and capsule forms as well as the raw material powder collected by the department during investigation into the pills contamination incident.
The 11 tainted samples comprised five from powder for making capsules and six in capsule form.
Investigations so far showed two of the capsules were made from powder prepared between late 2007 and early 2008, by a source that has not yet been revealed.
It was different from the one which Li Chung Shing Tong had been dealing with since the capsule form's launch in 2001. Another four capsule samples and all the five powder samples were traced to another powder supplier which the manufacturer had patronised just once in May 2008. The department and Guangdong health authorities are working closely to look for details on this plant which is not on any of Guangdong's drug manufacturer records.
The department said results in hand pointed towards Li Chung Shing Tong's failure to exercise due diligence to ensure its products' safety and quality.
The manufacturer has so far recalled about 7,585 boxes of capsule form and about 176,000 boxes of bottle form of the pills.
http://www.news.gov.hk/en/category/healthandcommunity/100330/html/100330en05003.htm Traditional ChineseSimplified ChineseText onlyPDARSS
*
March 25, 2010
Drug safety
*
Po Chai pills recall reports ordered
*
Department of Health
The Department of Health has directed licensed proprietary Chinese medicine manufacturer Li Chung Shing Tong (Holdings) Ltd HK to submit progress reports on the recall of its two forms of Po Chai pills.
The department yesterday ordered all the company's Po Chai pills in both capsule and bottle forms removed from local retail outlets and consumers after learning the Singaporean authority had detected the banned cancer-causing drug phenolphthalein and anti-obesity drug sibutramine in the capsule form. Singapore started a recall on March 8, and notified Hong Kong yesterday.
Health department staff questioned the company's employees yesterday, searched documents and seized products for analysis.
So far, investigations suggest the contamination source was likely to be in one batch of powder-form raw materials used to fill the capsules. The company had purchased it from a new Mainland source in May 2008.
The department said it understands two batches of capsules had been produced using the suspicious set of raw materials. One batch (no. 21217) was exported to Singapore, while the other batch (no. 21133) was supplied to Hong Kong and Macau markets. These are the only three places where the capsule form is marketed. Government tests on samples from both batches confirmed the detection of the two drugs.
The manufacturer, the department found, had actually initiated a recall from the retailers on its own accord in January after discovering the presence of the two Western pharmaceutical ingredients through its own testing. It had not, however, reported this action to the department, nor had it informed the department of the Singapore recall order - even though the practising guidelines for medicine manufacturers make this requirement clear.
Barred from further supply
The department said the recall of all Li Chung Shing Tong products, including the pills in bottle form, is a precautionary but necessary measure for the best protection of public health, as the products are widely and commonly used in the local community, with patrons from vulnerable groups including children and seniors.
The manufacturer has been barred from supplying further stocks of any of its products to the market until it can prove to the department's satisfaction that it has adequate control over the entire production process, particularly on the safety and quality of raw materials used.
The department is working closely with its Mainland and Singaporean counterparts to gain a complete picture of the matter.
http://www.news.gov.hk/en/category/healthandcommunity/100325/html/100325en05010.htm